Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.
Pigmentary aberrations are well known side effects of cytostatic chemotherapeutic agents. We report an unusual pattern of supravenous hyperpigmentation occurring after CHOP chemotherapy.